Tech Company Acquirers
Zalicus
Zalicus, operating out of Cambridge, bought EPIRUS Biopharmaceuticals.
Company Overview
Company Name
Zalicus
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Acquisitions
Contact Information
Mailing Address
245 First St. 3rd Floor
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Company Background Information
Overview
Our pipeline includes Exalgo (hydromorphone HCl) extended-release tablets, for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time and Synavive, in Phase 2 development for rheumatoid arthritis.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/16/2014
Acquisitions By Zalicus
Date
Company
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Corrigan
Chief Financial Officer
Justin Renz
Browse more tech company acquirers:
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs